Home › About Us › Our Staff › Molika Ashford

Molika Ashford

Editor
Phone Number
+1-212-651-5631
Email
mashford@genomeweb.com
Molika Ashford at Genomeweb / 360dx Molika Ashford at Genomeweb / 360dx

Molika Ashford covers personalized medicine and molecular diagnostics for GenomeWeb.

Articles Authored by Molika Ashford

Jan 18, 2019

Liquid Biopsy Panel Expansion Enables Admera Health to Add Immunotherapy Prediction

Premium

The firm's has expanded its ctDNA sequencing test to cover 17 genes, enough to provide a readout of microsatellite instability for guiding cancer immunotherapy use.

Jan 09, 2019

Scipher Medicine Builds Evidence for Tests Predicting Response to Autoimmune Disease Drugs

Premium

The company believes it can provide tests to predict patients' responsiveness to specific drugs akin to the molecular diagnostics that have now swelled the oncology space.

Jan 07, 2019

Genomic Health CEO Lays Out Plans to Increase Adoption, Push International Expansion

CEO Kim Popovits discussed three strategic imperatives for the coming year: increasing penetration in established markets, broadening global access, and continuing to diversify its portfolio.

Dec 28, 2018

Resolution Bioscience Holds Focus on Liquid Biopsy CDx, Kit Development as it Preps for Growth

Premium

The firm is moving into a larger facility after its first full year of profitability and planning new hires to support its plans to bring liquid biopsy kits through the FDA.

Dec 27, 2018

Epigenomics Pushes New Promotion Efforts for ProColon Test as Other Assays in Pipeline Advance

Premium

The firm has struggled in the past to convince payors of its test's clinical utility but remains dedicated to convincing the field that Epi proColon can help patients by closing CRC screening gaps.

Dec 14, 2018

Black Women With Breast Cancer Fare Worse, TAILORx Analysis Confirms at SABCS

Premium

A new analysis of the study yielded mixed news for black women, confirming that they suffer worse outcomes, even with the same genetic test results and treatment.

Dec 07, 2018

Study Adds to Evidence for Genelex PGx Testing But Proving Value Remains Difficult, Authors Say

Premium

A study of the detection of potential adverse drug events or interactions found that using PGx information led to better prediction of serious issues, despite no significant change overall.

Nov 20, 2018

Guardant Health Collecting Data to Make Case for 'Blood-First' Cancer Testing Paradigm

Premium

Following recent publications and anticipating the readout from its NILE study next year, the company plans to make the case that its liquid biopsy approach performs as well as tissue tests.

Nov 16, 2018

Agendia Breast Cancer Tests Show Promise for Improved Therapy Prediction

Premium

In the I-SPY 2 trial, investigators analyzed whether MammaPrint scores and BluePrint subtypes could help identify patients who would respond better to treatments.

Nov 15, 2018

Laboratory for Advanced Medicine Shares New Data on IvyGene Test Performance in Liver Cancer

Premium

Investigators shared data at an oncology meeting last week, showing that the test has high sensitivity and specificity in a blinded case-control cohort that included early-stage tumors.

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.